Breaking News Instant updates and real-time market news.

ELGX

Endologix

$1.86 /

+0.01 (+0.54%)

, FPRX

Five Prime

$5.00 /

+0.04 (+0.81%)

10:25
01/16/20
01/16
10:25
01/16/20
10:25

JPMorgan to hold a conference

38th Annual Healthcare Conference is being held in San Francisco on January 13-16 with webcasted company presentations to begin on January 16 at 10:30 am; not all company presentations may be webcasted. Webcast Link

ELGX

Endologix

$1.86 /

+0.01 (+0.54%)

FPRX

Five Prime

$5.00 /

+0.04 (+0.81%)

HMSY

HMS Holdings

$29.87 /

+0.64 (+2.19%)

IDRA

Idera Pharmaceuticals

$1.91 /

+0.035 (+1.87%)

LXRX

Lexicon

$4.37 /

+0.115 (+2.70%)

RIGL

Rigel Pharmaceuticals

$3.00 /

+0.27 (+9.89%)

TRXC

TransEnterix

$1.59 /

-0.03 (-1.85%)

NVDA

Nvidia

$248.87 /

+3.35 (+1.36%)

JNCE

Jounce Therapeutics

$7.96 /

+0.275 (+3.58%)

GRTS

Gritstone Oncology

$11.94 /

+0.6 (+5.29%)

STRO

Sutro Biopharma

$11.83 /

+ (+0.00%)

ZIOP

Ziopharm

$5.04 /

+0.09 (+1.82%)

IMGN

ImmunoGen

$4.93 /

-0.02 (-0.40%)

ATRC

AtriCure

$36.13 /

+0.79 (+2.24%)

ACOR

Acorda Therapeutics

$2.14 /

+0.015 (+0.71%)

ARNA

Arena Pharmaceuticals

$46.25 /

+1.1 (+2.44%)

KURA

Kura Oncology

$13.02 /

+0.15 (+1.17%)

NXTC

NextCure

$54.34 /

+0.95 (+1.78%)

VEEV

Veeva

$146.52 /

+2 (+1.38%)

RVNC

Revance

$22.84 /

-0.06 (-0.26%)

ISEE

Iveric bio

$6.81 /

+ (+0.00%)

INSP

Inspire Medical

$82.38 /

+1.13 (+1.39%)

CLSD

Clearside Biomedical

$2.45 /

+0.07 (+2.94%)

MSON

Misonix

$18.93 /

+ (+0.00%)

KRTX

Karuna Therapeutics

$85.65 /

+0.37 (+0.43%)

  • 16

    Jan

  • 30

    Jan

  • 06

    Feb

  • 10

    Feb

ELGX Endologix
$1.86 /

+0.01 (+0.54%)

04/01/19 PIPR
Piper Jaffray sees Endologix's updates as 'positive'
05/02/19 PIPR
Endologix earnings call brighter but risks remain, says Piper Jaffray
10/28/19 PIPR
FDA notice another negative data point for Endologix, says Piper Jaffray
FPRX Five Prime
$5.00 /

+0.04 (+0.81%)

06/03/19
Five Prime downgraded to Market Perform following ASCO data at Wells Fargo
09/30/19 GUGG
Five Prime downgraded to Neutral from Buy at Guggenheim
10/01/19 GUGG
Five Prime cut to Neutral after ESMO readout, management exits at Guggenheim
11/20/19 GUGG
Five Prime assumed with a Neutral at Guggenheim
HMSY HMS Holdings
$29.87 /

+0.64 (+2.19%)

01/08/20 FBCO
HMS Holdings reinstated with an Outperform at Credit Suisse
11/22/19 GUGG
Guggenheim upgrades HMS Holdings to Buy on 'compelling' risk/reward
08/22/19 GUGG
HMS Holdings downgraded to Neutral after 'impressive run' at Guggenheim
11/22/19 GUGG
HMS Holdings upgraded to Buy from Neutral at Guggenheim
IDRA Idera Pharmaceuticals
$1.91 /

+0.035 (+1.87%)

03/07/19 WEDB
Idera Pharmaceuticals price target lowered to $7 from $16 at Wedbush
03/08/19 HCWC
Idera Pharmaceuticals price target lowered to $14 from $18 at H.C. Wainwright
LXRX Lexicon
$4.37 /

+0.115 (+2.70%)

12/20/19 STFL
Stifel says Lexicon 'missed opportunity' with sotagliflozin data
12/11/19 GABE
Lexicon downgraded to Hold from Buy at Gabelli
11/08/19 SBSH
Lexicon downgraded to Neutral from Buy at Citi
12/11/19 GABE
Lexicon downgraded to Hold on valuation at Gabelli
RIGL Rigel Pharmaceuticals
$3.00 /

+0.27 (+9.89%)

01/16/20 HCWC
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
11/15/19
Fly Intel: Top five analyst initiations
11/15/19 CANT
Rigel Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
01/13/20 PIPR
Rigel still one of the most under-appreciated stories in sector, says Piper
TRXC TransEnterix
$1.59 /

-0.03 (-1.85%)

08/08/19 RBCM
TransEnterix downgraded to Sector Perform from Outperform at RBC Capital
05/22/19 PIPR
TransEnterix initiated with a Neutral at Piper Jaffray
05/22/19
Fly Intel: Top five analyst initiations
07/11/19 PIPR
TransEnterix asset sale doesn't change thesis, says Piper Jaffray
NVDA Nvidia
$248.87 /

+3.35 (+1.36%)

01/15/20 PIPR
Piper sees 2020 as 'major recovery year' for Semiconductors
01/13/20 CHLM
Nvidia price target raised to $300 from $255 at Craig-Hallum
01/13/20
Fly Intel: Top five analyst upgrades
01/13/20 NEED
Nvidia upgraded to Hold from Underperform at Needham
JNCE Jounce Therapeutics
$7.96 /

+0.275 (+3.58%)

GRTS Gritstone Oncology
$11.94 /

+0.6 (+5.29%)

03/27/19 BREN
Gritstone Oncology initiated with a Buy at Berenberg
03/14/19 RAJA
Gritstone Oncology initiated with an Outperform at Raymond James
07/26/19
Fly Intel: Top five analyst initiations
07/25/19 BARD
Gritstone Oncology initiated with an Outperform at Baird
STRO Sutro Biopharma
$11.83 /

+ (+0.00%)

09/05/19 JMPS
Sutro Biopharma resumed with an Outperform at JMP Securities
01/13/20 RHCO
Sutro Biopharma initiated with a Buy at SunTrust
10/07/19 BTIG
Sutro Biopharma initiated with a Buy at BTIG
10/07/19
Fly Intel: Top five analyst initiations
ZIOP Ziopharm
$5.04 /

+0.09 (+1.82%)

04/04/19 LSCM
Ziopharm initiated with a Buy at Lake Street
08/22/19 RAJA
Ziopharm resumed with an Outperform at Raymond James
04/01/19 LDLW
Ziopharm initiated with a Buy at Laidlaw
08/23/19
Fly Intel: Top five analyst initiations
IMGN ImmunoGen
$4.93 /

-0.02 (-0.40%)

12/17/19 HCWC
ImmunoGen price target hiked to $9 after 'compelling' advance at H.C. Wainwright
05/15/19 GUGG
ImmunoGen downgraded to Neutral from Buy at Guggenheim
05/15/19 HCWC
H.C. Wainwright says 'wrong again' about ImmunoGen, lowers price target to $4
09/29/19 PIPR
Biomarker screening reason for ImmunoGen FORWARD I failure, says Piper Jaffray
ATRC AtriCure
$36.13 /

+0.79 (+2.24%)

01/07/20 PIPR
Piper Sandler remains bullish on AtriCure as aMAZE enrollment completes
09/20/19 PIPR
AtriCure one of the most compelling names in cardiology, says Piper Jaffray
12/02/19 PIPR
Piper sees 'significant valuation creation on the horizon' for AtriCure
01/13/20 PIPR
AtriCure 2020 outlook likely to be conservative, says Piper Sandler
ACOR Acorda Therapeutics
$2.14 /

+0.015 (+0.71%)

08/14/19 HCWC
Acorda Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/24/19 JPMS
Acorda Therapeutics downgraded to Underweight from Neutral at JPMorgan
09/30/19 BOFA
Adamas Pharmaceuticals downgraded to Underperform from Neutral at BofA/Merrill
10/24/19 JPMS
JPMorgan downgrades Acorda to Underweight on disappointing Inbrija launch
ARNA Arena Pharmaceuticals
$46.25 /

+1.1 (+2.44%)

01/08/20 JMPS
Arena Pharmaceuticals has right management team in place, says JMP Securities
04/03/19 FBCO
Arena Pharmaceuticals price target raised to $77 from $63 at Credit Suisse
01/29/19
Fly Intel: Top five analyst initiations
11/13/19 BOFA
Arena Pharmaceuticals initiated with a Neutral at BofA/Merrill
KURA Kura Oncology
$13.02 /

+0.15 (+1.17%)

10/29/19 PIPR
Kura pivotal trial 'highly likely to succeed,' says Piper Jaffray
11/07/19 WEDB
Wedbush still views Kura Oncology as a top pick
07/18/19 DBAB
Kura Oncology initiated with a Buy at Deutsche Bank
09/05/19 JMPS
Kura Oncology resumed with an Outperform at JMP Securities
NXTC NextCure
$54.34 /

+0.95 (+1.78%)

01/13/20 PIPR
Partnership termination not a negative for NextCure N318, says Piper Sandler
01/06/20 PIPR
NextCure named a top pick for 2020 at Piper Sandler
01/13/20 RHCO
NextCure initiated with a Buy at SunTrust
12/05/19 NEED
NextCure initiated with a Buy at Needham
VEEV Veeva
$146.52 /

+2 (+1.38%)

01/13/20 MSCO
Veeva upgraded to Overweight from Equal Weight at Morgan Stanley
01/07/20 DBAB
Veeva price target lowered to $150 from $160 at Deutsche Bank
01/13/20 MSCO
Veeva upgraded to Overweight following underperformance at Morgan Stanley
12/26/19 STFL
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
RVNC Revance
$22.84 /

-0.06 (-0.26%)

10/30/19 WELS
Wells Fargo upgrades Revance to Outperform, boosts target to $20
10/30/19 WELS
Revance upgraded to Outperform from Market Perform at Wells Fargo
01/10/20 WBLR
Revance deal positions it as 'emerging aesthetics leader,' says William Blair
12/01/19 GSCO
Revance initiated with a Buy at Goldman Sachs
ISEE Iveric bio
$6.81 /

+ (+0.00%)

01/06/20 WEDB
IVERIC bio initiated with an Outperform at Wedbush
01/07/20
Fly Intel: Top five analyst initiations
01/06/20 WEDB
Wedbush starts Iveric bio with Outperform rating, $13 price target
INSP Inspire Medical
$82.38 /

+1.13 (+1.39%)

11/06/19 BREN
Inspire Medical upgraded to Hold from Sell at Berenberg
01/16/20 WELS
Inspire Medical price target raised to $90 from $70 at Wells Fargo
07/08/19 BOFA
Inspire Medical price target raised to $75 from $65 at BofA/Merrill
09/27/19 DOTC
Inspire Medical received positive draft LCDs from two more MACs, says Dougherty
CLSD Clearside Biomedical
$2.45 /

+0.07 (+2.94%)

10/14/19 ROTH
Ophthalmic therapies 'could go from 0 to 100 real quick,' says Roth Capital
08/13/19 LDLW
Laidlaw downgrades Clearside Biomedical to Hold after Xipere partnering
08/22/19 JMPS
Clearside Biomedical price target lowered to $3 from $4 at JMP Securities
12/17/19 JMPS
FDA to accept RVO clinial use data from Clearside, says JMP Securities
MSON Misonix
$18.93 /

+ (+0.00%)

12/31/19 CHLM
Misonix's amended credit line removes capital needs questions, says Craig-Hallum
06/12/19
Fly Intel: Top five analyst initiations
06/12/19 BTIG
Misonix initiated with a Buy at BTIG
08/15/19 ADAM
Misonix price target raised to $30 from $24 at Canaccord
KRTX Karuna Therapeutics
$85.65 /

+0.37 (+0.43%)

12/19/19 STFL
Karuna Therapeutics initiated with a Buy at Stifel
01/14/20 WBLR
Karuna Therapeutics' KarXT surpasses expectations, says William Blair
12/12/19 WBLR
Karuna Therapeutics initiated with an Outperform at William Blair
01/09/20 JMPS
Karuna Therapeutics initiated with an Outperform at JMP Securities

TODAY'S FREE FLY STORIES

General news
FX Action: USD-CAD has consolidated in the lower 1.3100s » 03:50
01/24/20
01/24
03:50
01/24/20
03:50

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: Narrow ranges have been seen » 03:25
01/24/20
01/24
03:25
01/24/20
03:25

FX Update: Narrow ranges…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: Narrow ranges have been seen » 03:15
01/24/20
01/24
03:15
01/24/20
03:15

FX Update: Narrow ranges…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian Market Update: » 01:50
01/24/20
01/24
01:50
01/24/20
01:50

Asian Market Update:…

Asian Market Update: Treasury yields are up 0.7 bp at 1.739% as Asian stock markets stabilised. Wall Street managed to claw back early losses to close little changed on Thursday and sentiment in Asia also improved somewhat, with most indices moving slightly higher, despite the spreading of the Wuhan coronavirus. Up to 10 cities across China are now reported to be in lockdown and the death-toll is rising. The number of cases outside of China is also rising although the WHO stepped short of declaring a Public Health Emergency of International Concern (PHEIC) yesterday, which helped to calm nerves. Mainland China bourses are now closed for the Lunar New Year holiday's, but the Hang Seng managed to move up 0.15%. Topix and Nikkei are down -0.06% and up 0.13% respectively and the ASX lifted 0.04%. U.S. futures are posting gains of around 0.1-0.2%. On the data front Japan core CPI came in a tad higher than expected and lifted to 0.7% from 0.5%, but this is still far below target. Australia PMI readings signaled continued decline in business activity, but after the strong employment report this week Westpac still dropped its rate cut forecast for February. USD-JPY is little changed at 109.53 and the front end WTI future is trading at USD 55.83 per barrel.

Syndicate
Applied Therapeutics 2.74M share Secondary priced at $45.50 » 23:52
01/23/20
01/23
23:52
01/23/20
23:52
APLT

Applied Therapeutics

$48.96 /

+0.6 (+1.24%)

The deal size was…

The deal size was increased from 1.75M shares and priced below the last close price of $48.85. Goldman Sachs, Cowen and UBS are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24
    Jan
Syndicate
Adaptive Biotechnologies 8M share Secondary priced at $26.50 » 23:50
01/23/20
01/23
23:50
01/23/20
23:50
ADPT

Adaptive Biotechnologies

$26.86 /

-0.34 (-1.25%)

JPMorgan, Goldman Sachs,…

JPMorgan, Goldman Sachs, BofA, Cowen, Guggenheim and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24
    Jan
Hot Stocks
Pacific City Financial raises quarterly dividend to 10c from 8c per share » 20:43
01/23/20
01/23
20:43
01/23/20
20:43
PCB

Pacific City Financial

$15.41 /

+0.09 (+0.59%)

The dividend will be paid…

The dividend will be paid on or about March 13, 2020, to shareholders of record as of the close of business on February 28, 2020.

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/23/20
01/23
20:25
01/23/20
20:25
AXP

American Express

$131.40 /

-0.16 (-0.12%)

, NEE

NextEra Energy

$260.00 /

+0.15 (+0.06%)

, SYF

Synchrony

$36.19 /

-0.23 (-0.63%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include NextEra Energy (NEE), consensus $1.50... American Express (AXP), consensus $2.01... Synchrony (SYF), consensus $1.07.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump to sign USMCA trade deal on Wednesday, Reuters says » 20:11
01/23/20
01/23
20:11
01/23/20
20:11
SPY

SPDR S&P 500 ETF Trust

$331.81 /

+0.41 (+0.12%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

President Donald Trump…

President Donald Trump will sign the U.S.-Mexico-Canada Agreement on trade in a White House ceremony next Wednesday, Reuters' Jeff Mason writes, citing a source with the administration. The official calls the agreement a "major accomplishment" for the President after he pledged to overhaul NAFTA as a political candidate, Mason writes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Investar Holding reports Q4 EPS 39c, consensus 48c » 19:36
01/23/20
01/23
19:36
01/23/20
19:36
ISTR

Investar Holding

$23.56 /

-0.48 (-2.00%)

Reports Q4 revenue…

Reports Q4 revenue $25.1M, consensus $18.88M. Reports Q4 net interest margin 3.44% vs. 3.53% last year. CEO John D'Angelo says: "Although we achieved a great deal during the quarter, our earnings were negatively impacted by additional provision expense of $0.2 million resulting from our strong loan growth which occurred late in the quarter, additional interest expense of $0.2 million on our $25.0 million subordinated debt, $0.2 million of legal expenses related to an acquired asset, $0.2 million of noninterest expense for our two new branches, and $0.3 million of additional expense for Louisiana Bank Shares Tax related to our growth."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Death toll related to China coronavirus has risen to 25 from 18, Bloomberg says  19:27
01/23/20
01/23
19:27
01/23/20
19:27
SPY

SPDR S&P 500 ETF Trust

$331.81 /

+0.41 (+0.12%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Turk Telekom upgraded to Buy from Neutral at Goldman Sachs » 19:11
01/23/20
01/23
19:11
01/23/20
19:11
TRKNY

Turk Telekom

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Vyacheslav Degtyarev upgraded Turk Telekom to Buy from Neutral with a price target of TRY 10.6, up from TRY 6.9. The analyst anticipates a gradual dividend restoration for the company in 2020 amid improved macro conditions, strengthened balance sheet, and "decent" profitability prospects.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Turk Telekom upgraded to Buy from Neutral at Goldman Sachs » 19:09
01/23/20
01/23
19:09
01/23/20
19:09
TRKNY

Turk Telekom

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Vyacheslav Degtyarev upgraded Turk Telekom to Buy and raised his price target to TRY10.6 from TRY6.9.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Heritage Commerce reports Q4 EPS 10c, consensus 24c » 19:06
01/23/20
01/23
19:06
01/23/20
19:06
HTBK

Heritage Commerce

$12.39 /

+0.01 (+0.08%)

"The fourth quarter…

"The fourth quarter of 2019 saw a significant accomplishment for Heritage Bank of Commerce with the completion of the Presidio Bank merger thereby creating the San Francisco Bay Area's premier community business bank with a strong depth of banking talent and an extensive and diverse customer base," said Keith A. Wilton, President and Chief Executive Officer. "Credit quality remains strong and the Bank continued to generate solid earnings for the fourth quarter and the full year of 2019, though these were partially reduced by anticipated merger-related costs from the Presidio merger."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Heritage Commerce increases quarterly dividend 8% to 13c per share » 19:05
01/23/20
01/23
19:05
01/23/20
19:05
HTBK

Heritage Commerce

$12.39 /

+0.01 (+0.08%)

Heritage Commerce Corp…

Heritage Commerce Corp announced that its Board of Directors increased its quarterly cash dividend 8% to $0.13 per share to holders of common stock. The dividend will be payable on February 19, 2020, to shareholders of record at close of business day on February 5, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 18:43
01/23/20
01/23
18:43
01/23/20
18:43
EHTH

eHealth

$97.09 /

-2.51 (-2.52%)

, TEAM

Atlassian

$132.89 /

+1.52 (+1.16%)

, INTC

Intel

$63.32 /

+0.53 (+0.84%)

, NXGN

NextGen Healthcare

$15.93 /

+0.04 (+0.25%)

, SIVB

SVB Financial

$259.41 /

+2.86 (+1.11%)

, FLR

Fluor

$19.97 /

+0.115 (+0.58%)

, AVGO

Broadcom

$319.73 /

+6.81 (+2.18%)

, DFS

Discover

$85.77 /

+0.405 (+0.47%)

, ISRG

Intuitive Surgical

$614.64 /

+4.41 (+0.72%)

, SWKS

Skyworks

$128.18 /

+3.18 (+2.54%)

, BANR

Banner Corp.

$54.20 /

+0.34 (+0.63%)

, ETFC

E-Trade

$46.07 /

-0.44 (-0.95%)

, CVTI

Covenant Transportation

$12.88 /

-0.3 (-2.28%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: eHealth (EHTH) up 15.6%... Atlassian (TEAM) up 9.7%... Intel (INTC) up 5.2%... NextGen Healthcare (NXGN) up 3.6%... SVB Financial (SIVB) up 3.1%. ALSO HIGHER: Fluor (FLR) up 7.8% after its Stork JV was awarded engineering services contract for Dutch assets... Broadcom (AVGO) up 2.3% after announcing new component deal with Apple. DOWN AFTER EARNINGS: Discover (DFS) down 5.8%... Intuitive Surgical (ISRG) down 2.9%... Skyworks (SWKS) down 2.5%... Banner Corp (BANR) down 2.2%... E-Trade (ETFC) down 2.1%... Covenant Transport (CVTI ) down 1.6%. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
GrubHub CEO: We haven't had any offers » 18:39
01/23/20
01/23
18:39
01/23/20
18:39
GRUB

GrubHub

$57.76 /

+1.395 (+2.48%)

In an interview on…

In an interview on CNBC's Mad Money, GrubHub CEO Matt Maloney discussed a Wall Street Journal story from earlier this month which claimed the company was weighing a possible sale. Maloney said, "We haven't had any offers to buy the company," and added that he had "no idea" where the WSJ sourced its information. Maloney said GrubHub was "revolutionizing pick up" with its new Ultimate technology solution for restaurants. He noted that the product has been evolving for five years and the company is working on several stadium deals. Maloney said the company's "large loyalty infrastructure" will assist in the roll-out of the new platform.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Axel Springer plans to delist from Frankfurt Stock Exchange » 18:22
01/23/20
01/23
18:22
01/23/20
18:22
AXELF

Axel Springer

$0.00 /

+ (+0.00%)

, KKR

KKR

$31.20 /

-0.29 (-0.92%)

Axel Springer (AXELF)…

Axel Springer (AXELF) plans to withdraw from the stock exchange. A respective application will be made at the Frankfurt Stock Exchange prior to the expiration of the acceptance period of the delisting offer. The withdrawal from the regulated market of the Frankfurt Stock Exchange requires a public delisting offer to the Axel Springer SE shareholders as a precondition so that shareholders can sell their shares prior to the termination of the stock listing. According to an agreement signed today with Axel Springer SE, KKR (KKR) will make such an offer with an offer price amounting to EUR63 in cash per share. This payment is equal to the offer price for the previous public tender offer which was closed in December 2019. In 2019, Axel Springer and KKR entered into an investment agreement for a strategic partnership aimed at supporting the long-term growth strategy. Through a public tender offer as well as additional purchases, KKR has acquired approximately 44.9% of Axel Springer's share capital. In the public tender offer document of 5 July 2019 KKR has already announced its intention to propose a delisting to the other consortium members and to the Executive Board of Axel Springer SE following the successful tender offer.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
GrubHub launches 'Ultimate technology' for restaurants » 18:20
01/23/20
01/23
18:20
01/23/20
18:20
GRUB

GrubHub

$57.76 /

+1.395 (+2.48%)

Grubhub launched its…

Grubhub launched its Ultimate technology, "a revolutionary, first-of-its-kind proprietary hardware and software solution that integrates all restaurant ordering channels into one system." Replacing error-prone handwritten scribbles and shouts, Ultimate is a digital workflow solution, connecting the front- and back-of-the house directly with diners and creating a transparent view into their order status - whether diners order for pickup or delivery on Grubhub, at an in-store kiosk, or directly with a cashier.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Noble Midstream raises quarterly dividend to 68.8c from 67.2c per share » 18:16
01/23/20
01/23
18:16
01/23/20
18:16
NBLX

Noble Midstream

$23.40 /

-0.75 (-3.11%)

The dividend will be…

The dividend will be payable on February 14, 2020 to unitholders of record as of February 4, 2019.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SPDR Gold Shares holdings rise to 900.58MT from 898.82MT » 18:14
01/23/20
01/23
18:14
01/23/20
18:14
GLD

SPDR Gold Shares

$147.11 /

+0.33 (+0.22%)

This is the highest level…

This is the highest level of holdings since November 11th.

Periodicals
Sonos CEO apologizes for perceived 'planned obsolescence' move, Verge reports » 18:04
01/23/20
01/23
18:04
01/23/20
18:04
SONO

Sonos

$14.35 /

-0.115 (-0.80%)

Chris Welch of the Verge…

Chris Welch of the Verge writes that Sonos CEO Patrick Spence tried to "clear up an announcement" from earlier this week that stated the company will "cease delivering software updates and new features to its oldest products in May." Amid criticisms that the company was instigating a planned obsolescence, Sonos CEO Patrick Spence apologized "for any confusion" and reassured the company's customers "that the so-called legacy products," including the original Sonos Play:5, Zone Players, and Connect / Connect:Amp will "continue to work as they do today," according to the Verge story. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Carlyle's Rubenstein says eyeing 'relatively cheap' energy assets, Reuters says » 17:58
01/23/20
01/23
17:58
01/23/20
17:58
CG

Carlyle Group

$34.52 /

+0.24 (+0.70%)

Carlyle founder and…

Carlyle founder and co-executive chairman David Rubenstein said that worries about the future of energy assets have led to a selloff, but this has created "very good opportunities" for the private equity firm, Reuters' Divya Chowdhury and Aaron Saldanha report. Rubenstein told the Reuters Global Markets Forum that securing bank loans for such deals, however, have become more difficult. "Right now, energy is relatively cheap and therefore we are looking at lot of assets where there has been a sell-off in the value, in part because people are nervous about the future of carbon energy," he said. "So we still think there are very good opportunities there." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Insys founder sentenced to 66 months in prison over bribery scheme, Reuters says » 17:56
01/23/20
01/23
17:56
01/23/20
17:56
INSY

Insys Therapeutics

$0.00 /

+ (+0.00%)

Insys Therapeutics…

Insys Therapeutics founder John Kapoor has been sentenced to 66 months in prison for his role in a bribery and fraud scheme that ultimately played a role in the U.S. opioid crisis, Reuters' Tim McLaughlin reports. Kapoor is now the highest-ranking pharmaceutical executive to be sentenced in a case connected to the drug crisis, McLaughlin says. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Uber expects to begin operating in Vancouver soon, Bloomberg says » 17:52
01/23/20
01/23
17:52
01/23/20
17:52
UBER

Uber

$37.40 /

+0.33 (+0.89%)

Uber will finally start…

Uber will finally start operating in Vancouver, British Columbia, Bloomberg's Gerrit De Vynck reports. Vancouver was originally one of the ride-hailing giant's first targeted destinations outside of the U.S., but provincial authorities quickly rebuffed them, De Vynck notes. "We received authorization from the passenger transportation board to provide service across Metro Vancouver," Michael van Hemmen, an Uber spokesman, said at a press conference. "We expect to be available in the next few days." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.